FDA Inspection
N-Molecular Inc. d.b.a. SOFIEN-Molecular Inc. d.b.a. SOFIE – FDA Inspection, Nov 20, 2024
Record Details
This FDA Inspection record concerns N-Molecular Inc. d.b.a. SOFIE, with an inspection on November 20, 2024, issued by the New England District Office, covering human drugs.
View Company Profile
ID · 495238da-8681-42f9-8d32-5e8afa326281
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1250020
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 212.20(e)Written QA procedures established, followed
- 21 CFR 212.50(c)(8)Testing results
- 21 CFR 212.30(c)Contact surfaces
Full citation text and observation details available on the Dashboard.
Other FDA inspections of N-Molecular Inc. d.b.a. SOFIE
4| Date | Classification | Office | Project area |
|---|---|---|---|
| May 16, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 28, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 7, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 11, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for N-Molecular Inc. d.b.a. SOFIE
- FDA Inspection 1089718 - 2019-05-16
- FDA Inspection 1042553 - 2018-02-28
- FDA Inspection 939620 - 2015-08-07
- FDA Inspection 859853 - 2013-12-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.